US OptionsDetailed Quotes

UTHR241220P220000

Watchlist

3.00
0.000.00%

15min DelayClose Nov 21 16:00 ET

0.00High0.00Low

United Therapeutics Stock Discussion

Teddy123

Sep 24 06:15

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2024 Annual Meeting

$United Therapeutics (UTHR.US)$
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2024 Annual Meeting | UTHR Stock News

Tonyco

Jul 3 23:49

$United Therapeutics (UTHR.US)$
lol that is a shit ton of inside selling all at the end of June

Meltyy

May 12 21:23

🎯 Ph 3 readouts in Q2 2024...

$United Therapeutics (UTHR.US)$ Phase 3
$Ironwood Pharmaceuticals (IRWD.US)$ Phase 3
$Liquidia (LQDA.US)$ Phase 3
$United Therapeutics (UTHR.US)$ Phase 3
$MorphoSys (MOR.US)$ Phase 3
$Immunocore (IMCR.US)$ Phase 3
$Crinetics (CRNX.US)$ Phase 3
$UroGen Pharma Ltd (URGN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$Capricor Therapeutics (CAPR.US)$ Phase 3
$Annexon (ANNX.US)$ Phase 3
$Lipocine (LPCN.US)$ Phase 3...

Meltyy

Apr 18 03:34

🎯 Ph 3 readouts in Q2 2024...

$Travere Therapeutic (TVTX.US)$ Phase 3
$CG Oncology (CGON.US)$ Phase 3
$United Therapeutics (UTHR.US)$ Phase 3
$United Therapeutics (UTHR.US)$ Phase 3
$BioCardia (BCDA.US)$ Phase 3
$Insmed (INSM.US)$ Phase 3
$GlycoMimetics (GLYC.US)$ Phase 3
$Annexon (ANNX.US)$ Phase 3
$Lipocine (LPCN.US)$ Phase 3
$FibroGen (FGEN.US)$ Phase 3
$UroGen Pharma Ltd (URGN.US)$ Phase 3
$Lyra Therapeutics (LYRA.US)$ Phase 3
$Citius Pharmaceuticals (CTXR.US)$ Phase 3
$Jaguar Health (JAGX.US)$ Phas...

zcole1101

Jan 5 01:02

Are you a high net profit margin lover? So you will like these 1⃣2⃣ stocks with a net profit margin above 4⃣0⃣%
🇺🇸 Texas Pacific Land $Texas Pacific Land (TPL.US)$ 63.3%
🇸🇪 Evolution $Evotec (EVO.US)$ 59.3%
🇺🇸 CME Group $CME Group (CME.US)$ 57.1%
🇺🇸 Visa $Visa (V.US)$ 55.3%
🇬🇧 Rightmove $RIGHTMOVE ADR (RTMVY.US)$ 54.8%
🇺🇸 Verisign $VeriSign (VRSN.US)$ $50.1%
🇦🇺 Pro Medicus $Pingtan Marine Enterprise (PME.US)$ 49.8%
🇺🇸 NVidia $NVIDIA (NVDA.US)$ 47.3%
🇺🇸 Mastercard $MasterCard (MA.US)$ 45.1%
🇫🇷 GTT $GTT Communications, Inc. (GTTN.US)$ 44.8%...

Moomoo AI

Jan 2 07:57

The low P/E despite solid growth numbers seems to stem from investor sentiment, possibly from certain unobserved threats affecting the stock. Some shareholders might be skeptical of the earnings forecasts, indicating potential earnings instability.

Cautious Investors Not Rewarding United Therapeutics Corporation's (NASDAQ:UTHR) Performance Completely

Moomoo AI

Oct 26, 2023 07:44

United Therapeutics' strong financials could suggest long-term stock increase. Its net income growth might be due to good management and a low payout ratio, even though the earnings growth may slow down in future.

Is Weakness In United Therapeutics Corporation (NASDAQ:UTHR) Stock A Sign That The Market Could Be Wrong Given Its Strong Financial Prospects?

Moomoo Breakfast US

Aug 2, 2023 06:58

Columns Before the Bell | Stock Futures Fall After Fitch Downgrades U.S. Rating, Earnings Season Continues

$S&P 500 Index (.SPX.US)$ $NASDAQ 100 Index (.NDX.US)$ $Dow Jones Industrial Average (.DJI.US)$ $Nasdaq Composite Index (.IXIC.US)$ $Caterpillar (CAT.US)$ $Ferrari (RACE.US)$ $United Therapeutics (UTHR.US)$ $Unity Software (U.US)$ $Qualcomm (QCOM.US)$ $Shopify (SHOP.US)$ $PayPal (PYPL.US)$

Expand

Mooers Radar

May 3, 2023 17:35

Columns US Top Gap Ups and Downs on 5/3: AMD, VOD, SBUX, EL and More

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after the previous market closed (gaps range from large to small):
Gap Ups
1. $Unum Group (UNM.US)$ - up 5.1%
2. $Generac (GNRC.US)$ - up 5.0%
3. $Builders FirstSource (BLDR.US)$ - up 4.9%
4. $Livent (LTHM.US)$ - up 4.4%
5. $Pearson (PSO.US)$ - up 4.1%
6. $Verisk Analytics (VRSK.US)$ - up 3.6%
7. $Assurant (AIZ.US)$ - up 2.7%
8. $Vodafone (VOD.US)$ - up...

+16

BioPharm Insight US

Oct 17, 2022 05:36

Columns Weekly FDA Drug Pipeline Calendar (Oct 17- Oct 21)

Hello mooers, welcome to another week of the FDA calendar. Here are what happened last week and what's coming up this week.
Top Medical News of the Week
Moderna and Merck to develop a cancer vaccine for high-risk melanoma patients
Last week, we had some exciting news on cancer vaccine development announced by Moderna and Merck.
Moderna's vaccine, based on its messenger RNA technology, is being studied in combination with Merck's Keytruda to treat...

No comment yet